GKIM
TEVA icon

GW&K Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

GW&K Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Buy
495
+235
+90% +$7.83K ﹤0.01% 833
2026
Q1 		$8K Buy
260
+79
+44% +$2.54K ﹤0.01% 902
2025
Q4 		$6K Hold
181
– – ﹤0.01% 916
2025
Q3 		$4K Hold
181
– – ﹤0.01% 942
2025
Q2 		$3K Hold
181
– – ﹤0.01% 950
2025
Q1 		$3K Hold
181
– – ﹤0.01% 948
2024
Q4 		$4K Hold
181
– – ﹤0.01% 889
2024
Q3 		$3K Buy
181
+38
+27% +$665 ﹤0.01% 901
2024
Q2 		$2K Hold
143
– – ﹤0.01% 896
2024
Q1 		$2K Hold
143
– – ﹤0.01% 872
2023
Q4 		$1K Hold
143
– – ﹤0.01% 916
2023
Q3 		$1K Hold
143
– – ﹤0.01% 899
2023
Q2 		$1K Buy
+143
New +$1.16K ﹤0.01% 890

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

GW&K Investment Management's TEVA Position: Q2 2026 in Review

GW&K Investment Management increased its Teva Pharmaceuticals (TEVA) stake by 90% in Q2 2026, buying an estimated $7.83K and bringing the position to 495 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

GW&K Investment Management first reported a position in TEVA in Q2 2023 and has held it in 13 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • GW&K Investment Management held 495 shares of Teva Pharmaceuticals worth $17K as of Q2 2026.
  • GW&K Investment Management bought 235 Teva Pharmaceuticals shares in Q2 2026, an estimated $7.83K.
  • Teva Pharmaceuticals made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #833 holding.
  • GW&K Investment Management first reported a position in Teva Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.